Ursodeoxycholic acid reduces CpG‐induced IgM production in patients with primary biliary cirrhosis

Abstract

UDCA reduces total and IgM-AMA production in PBMC from patients with PBC by downregulating B cell activation and NF-kB signaling. These data ultimately suggest novel mechanisms of action for UDCA in chronic autoimmune cholestasis.